A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians
Botulinum toxin type A (BoNT-A) was first isolated in 1946, and since then, several formulations have been developed and widely used to treat wrinkles by inducing muscle paralysis. This multicenter, double-blind, randomized, parallel-group, active-controlled phase 3 clinical trial was designed to ev...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2024-12-01
|
| סדרה: | Journal of Dermatological Treatment |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2359511 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|